Se trata de una sociedad norteamericana con miembros muy reconocidos internacionalmente que celebra cada dos años su congreso fuera de EEUU (anteriores sedes: Estambul y Nápoles).

Este año, la sede es Málaga (Marbella; 16-19 de Junio -2013) con un atractivo programa científico y social que incluye una extensión cultural a Granada de dos días para aquellos que lo deseen.

Es posible por supuesto remitir comunicaciones a través de la web del congreso ( y de la SUN (

Curso mundial de neurooncología quirúrgica


Segundo curso mundial anual en técnicas avanzadas de neurooncología quirúrgica

Organizado por el departamento de Neurocirugía Victor Horsley, Queen Square en Londres.

11 a 14 julio 2013.


El curso está dirigido tanto a neurocirujanos experimentados como principiantes.

Durante 4 días (de jueves a domingo), con los neurocirujanos oncológicos más famosos del mundo.

Mitchel Berger de EE.UU. llevará a cabo una craneotomía despierta con mapeo cortical sobre un paciente con un glioma de bajo grado en un área elocuente.

Hughues Duffau de Francia realizará una resección supracompleta sin neuronavegación en un paciente con glioma de bajo grado en área elocuente.

Walter Stummer de Alemania realizará una craneotomía despierta y una resección guiada con fluorescencia en un paciente con un glioma de alto grado.

Update: Steroids for brain abscess

Steroids for brain abscess

Steroids for Brain Abscess is controversial.

Reduces edema, but may reduce antibiotic penetration into abscess 1).

It seems to only partially inhibit adequate concentrations of antibiotics in brain tissue dependent upon the antibiotics used 2).

Immune supression may also be deleterious.

There is no well-controlled, randomized clinical study evaluating the use of corticosteroids for controlling the cerebral edema surrounding BA; nevertheless, corticosteroids are recommended perioperatively for reducing intracranial pressure and avoiding acute brain herniation 3) but only in those patients that demonstrate signs of meningitis or disproportionate cytotoxic edema posing a life-threatening problem 4).

Steroids can retard the encapsulation process, increase necrosis, reduce antibiotic penetration into the abscess, increase the risk of ventricular rupture, and alter the appearance on CT scans because of contrast reduction. Steroid therapy can also produce a rebound effect when discontinued. Corticosteroids are used when a significant mass effect is visible on imaging and the patient’s mental status is depressed. When used to reduce cerebral edema, therapy should be of short duration. The appropriate dosage, the proper timing, and any effect of steroid therapy on the course of the disease are unknown 5).

Case reports

A case of acute brain abscess in a 59-year-old man is presented. The primary CT findings were misinterpreted as a brain infarct or possibly a tumour. Under steroid therapy an activation of the brain abscess was observed in only nine days and in spite of an immediate operation the patient died 6).


Rosenblum ML, Hoff JT, Norman D, Edwards MS, Berg BO. Nonoperative treatment of brain abscesses in selected high-risk patients. J Neurosurg. 1980 Feb;52(2):217-25. PubMed PMID: 7351561.

Kourtópoulos H, Holm SE, Norrby SR. The influence of steroids on the penetration of antibiotics into brain tissue and brain abscesses. An experimental study in rats. J Antimicrob Chemother. 1983 Mar;11(3):245-9. PubMed PMID: 6841306.

Lee TH, Chang WN, Su TM, Chang HW, Lui CC, Ho JT, Wang HC, Lu CH. Clinical features and predictive factors of intraventricular rupture in patients who have bacterial brain abscesses. J Neurol Neurosurg Psychiatry. 2007 Mar;78(3):303-9. Epub 2006 Sep 29. PubMed PMID: 17012340; PubMed Central PMCID: PMC2117635.

Muzumdar D, Jhawar S, Goel A. Brain abscess: an overview. Int J Surg. 2011;9(2):136-44. doi: 10.1016/j.ijsu.2010.11.005. Epub 2010 Nov 16. Review. PubMed PMID: 21087684.

Strohecker J, Kollmann H, Piotrowski W, Grobovschek M. Exacerbation of brain abscess during exclusive treatment with steroids, demonstrated by computerised tomography. Neurochirurgia (Stuttg). 1985 Jan;28(1):20-1. PubMed PMID: 3974790.

Craniosynostosis: Developing Parameters for Diagnosis, Treatment, and Management

A multidisciplinary meeting was held from March 4 to 6, 2010, in Atlanta, Georgia, entitled “Craniosynostosis: Developing Parameters for Diagnosis, Treatment, and Management.” The goal of this meeting was to create parameters of care for individuals with craniosynostosis.

Fifty-two conference attendees represented a broad range of expertise, including anesthesiology, craniofacial surgery, dentistry, genetics, hand surgery, neurosurgery, nursing, ophthalmology, oral and maxillofacial surgery, orthodontics, otolaryngology, pediatrics, psychology, public health, radiology, and speech-language pathology. These attendees also represented 16 professional societies and peer-reviewed journals. The current state of knowledge related to each discipline was reviewed. Based on areas of expertise, four breakout groups were created to reach a consensus and draft specialty-specific parameters of care based on the literature or, in the absence of literature, broad clinical experience. In an iterative manner, the specialty-specific draft recommendations were presented to all conference attendees. Participants discussed the recommendations in multidisciplinary groups to facilitate exchange and consensus across disciplines. After the conference, a pediatric intensivist and social worker reviewed the recommendations.

Consensus was reached among the 52 conference attendees and two post hoc reviewers. Longitudinal parameters of care were developed for the diagnosis, treatment, and management of craniosynostosis in each of the 18 specialty areas of care from prenatal evaluation to adulthood.

This is the first multidisciplinary effort to develop parameters of care for craniosynostosis. These parameters were designed to help facilitate the development of educational programs for the patient, families, and health-care professionals; stimulate the creation of a national database and registry to promote research, especially in the area of outcome studies; improve credentialing of interdisciplinary craniofacial clinical teams; and improve the availability of health insurance coverage for all individuals with craniosynostosis.